第八届中国国际进口博览会将于11月5日至10日在上海召开。德国高端成人膳食营养品牌Mom's Garden 再度受邀参展，携旗下"Mom's Garden百草园"与"Mom's Garden任我行"两大子品牌联袂亮相。本届进博 会，Mom's Garden以"临床实证"为主题，集中呈现来自德国的科研创新成果，进一步夯实对中国消费者 的品质承诺。 连续参展的背后，是Mom's Garden与中国市场的一场"双向奔赴"。Mom's Garden全球品牌负责人Olga Stepanko表示："中国不仅是Mom's Garden全球战略中不可或缺的一环，更是品牌持续增长的核心引 擎。我们期待借助进博会的'溢出效应'，将更多基于德国科研、贴近中国需求的膳食营养解决方案引入 中国市场。" 作为推动"展品变商品、展商变投资商"的重要桥梁，进博会持续为全球企业共享中国机遇、深化本土合 作提供开放窗口。Mom's Garden高度重视这一契机，坚持以临床实证为基础期待借助进博会，将全球科 研优势与中国健康需求深度融合，打造更科学、更可信的营养解决方案。 从展示创新成果的"展品"，到走进中国家庭的"商品"，再到规划本土研发的"投 ...

Core Insights - The article highlights the increasing importance of clinical research and scientific data in the selection of children's nutritional products by parents [1][2] - Inne has made significant advancements in clinical projects through its Institute of Nutrition and Health, collaborating with various research institutions to validate the efficacy of its selected ingredients [1] - Recent research on Inne's DHA supplementation has shown improvements in memory in mice, with results published in the authoritative journal eFood, indicating the scientific credibility of the findings [1][2] Group 1 - Inne's recent academic conference focused on the clinical evidence of calcium supplementation, showcasing its commitment to scientific innovation in the children's nutrition sector [2] - The company has previously published research on its patented Kidtal ingredient, which enhances bone density and strength, in the well-known journal Nutrients [2] - Inne aims to transition the industry from experience-driven practices to evidence-based approaches, emphasizing the importance of rigorous clinical research in children's nutrition [2] Group 2 - The challenges of conducting clinical research in children's nutrition, including long research cycles and individual variability, are acknowledged as critical for industry advancement and consumer trust [2] - Inne plans to continue building a product matrix based on evidence-based medicine, translating cutting-edge research into practical health support for consumers [2] - The company aspires to define the "gold standard" in children's nutrition through clinical evidence, providing better nutritional choices for parents and children [2]

Core Viewpoint - The article emphasizes the urgent need for a scientific standard in calcium supplementation for children, highlighting the widespread issue of insufficient calcium intake and the confusion among parents regarding various products available in the market [1][2]. Group 1: Industry Developments - Inne has initiated a milestone academic conference titled "Clinical Evidence: A New Era of Scientific Calcium Supplementation," collaborating with various experts and industry leaders to discuss the significance of clinical evidence in driving industry standards [1][2]. - The conference has garnered significant attention from authoritative media outlets, marking a shift towards a more regulated and professional landscape in the children's nutrition industry, thereby establishing Inne's leadership position [2]. Group 2: Scientific Advancements - Inne is recognized as the first brand in the industry to systematically promote clinical validation, aiming to redefine industry standards through rigorous scientific research and evidence [2][8]. - The company has introduced innovative products, such as a liquid calcium supplement that addresses absorption issues, and has established a scientific age-based system for calcium supplementation [6][8]. Group 3: Expert Insights - Dr. Yu Wen, a pediatrician, emphasized the importance of clinical evidence as the gold standard for selecting calcium supplements, advocating for the necessity of clinical research to validate product effectiveness and safety [6][8]. - The latest research on Inne's patented ingredient, Kidtal, has been published in a top nutrition journal, demonstrating its unique advantages in promoting children's growth and development [8]. Group 4: Institutional Initiatives - Inne has established the Institute of Nutrition and Health to address the long-standing issue of unverifiable product claims in the children's nutrition sector, aiming to provide scientific validation for product safety and efficacy [9]. - The institute's establishment marks a new phase in Inne's commitment to scientific innovation and industry responsibility, encouraging other brands to prioritize clinical research [9]. Group 5: Consumer Perspectives - A prominent consumer representative highlighted the confusion parents face due to the overwhelming number of products lacking real clinical data, stressing that clinically validated products can alleviate parenting anxiety [10]. - The presence of clinical evidence provides parents with confidence in their choices, moving beyond mere marketing claims [10]. Group 6: Global Positioning - Inne adheres to German pharmaceutical standards and has received various certifications, ensuring high-quality production and safety for its products [11]. - The company has established partnerships with major pharmacies in Germany and has gained popularity in the Chinese market, leading sales on major e-commerce platforms [11]. Group 7: Future Directions - The successful conclusion of the academic conference sets a new standard for scientific calcium selection based on clinical evidence, positioning Inne as a leader in the children's nutrition field [12]. - Inne aims to continue leveraging evidence-based medicine to develop professional nutrition products that withstand clinical efficacy tests, driving transformative upgrades in the industry [12].

Core Insights - The 24th CBME International Baby, Maternity & Children Industry Expo in Shanghai showcased over 4,500 brands and attracted more than 100,000 professional visitors, marking a record scale for the event [1] - Inne, a German children's nutrition brand, highlighted its commitment to scientific nutrition through a groundbreaking academic conference focused on clinical evidence for calcium supplementation, shifting the industry towards evidence-based marketing [1][5] Group 1: Event Highlights - Inne's exhibition featured an immersive booth designed around the theme "Pinnacle Nutrition, Leading Growth," with a model of Mount Everest symbolizing the brand's pursuit of excellence [3] - The conference gathered industry experts and scholars, including notable figures from top hospitals, to discuss the importance of clinical evidence in advancing children's nutrition [5][6] Group 2: Product Innovations - Inne introduced upgraded products, including a liquid calcium supplement for children under 6 and a proprietary ingredient, Kidtal, aimed at enhancing bone growth during puberty, with research published in the journal "Nutrients" [4][6] - The company also presented clinically validated eye care products for children, which have shown effectiveness in alleviating visual fatigue and protecting against blue light damage [4][6] Group 3: Consumer Engagement - The exhibition attracted significant consumer interest, with interactive installations that allowed families to engage with the brand and learn about scientific nutrition [7] - Parents shared positive experiences with Inne products, emphasizing the brand's transparency in clinical research and its impact on children's health and growth [8] Group 4: Industry Impact - Inne's participation at CBME set a new benchmark for the industry by emphasizing the role of clinical evidence in driving high-quality development in children's nutrition [9] - The company plans to continue focusing on consumer needs and deepening clinical research to provide effective and transparent nutritional solutions for children's health [9]

7月16日，全球母婴行业年度盛典——第24届CBME国际孕婴童展在上海国家会展中心盛大启幕。本届 展会汇聚了全球4500余家孕婴童品牌参展，超10万名专业观众观展，规模再创新高。源自德国的儿童营 养品牌inne因你连续第三年参展，携旗下全系产品亮相。 展会首日，inne就在CBME 7.1馆隆重举办"临床实证：跨时代科学补钙"学术会议，特邀权威专家学者莅 临现场。此次会议开创了业内临床实证的先河，终结了"重概念轻实效"的纸上谈兵式营销，不仅为消费 者建立起以临床实证为核心的选钙"金标准"，更引领儿童营养行业实现从"经验主导"走向"临床实证"的 跨时代进化，在CBME现场引发热烈反响，并受到央视重点报道，成为本届展会最受瞩目的行业焦点之 一。 巅峰营养，成长领先 此次亮相，inne以"巅峰营养 成长领先"为主题打造的沉浸式展台成为全场焦点。 展台整体以壮阔的雪 山造型为基调，中央矗立着"世界之巅"珠穆朗玛峰的模型，这不仅是展台的视觉中心，更代表着inne "巅峰精神"的有力宣言——以"巅峰"为自驱力，不断挑战自我、攀登科研新高度的执着追求。 其中，竹节钙专利成分Kidtal 相关研究已发表于国际顶刊《Nutri ...

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a critical standard for evaluating children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][6]. Group 1: Industry Trends - The children's nutrition industry is transitioning from "experience-driven" to "evidence-based" approaches, with a focus on clinical validation to establish new standards for calcium supplementation [3][14]. - Over 50% of calcium supplements in the market are still basic forms like calcium carbonate and lactate, with only 15% having undergone clinical trials, indicating a significant gap in scientific validation [4][6]. Group 2: Company Initiatives - Inne, a German-origin children's nutrition brand, has launched a comprehensive clinical validation system and hosted an academic conference titled "Clinical Validation: A Revolutionary Approach to Scientific Calcium Supplementation" [1][3]. - The company has established global research centers in Germany, China, Australia, and the USA, focusing on high-absorption, preservative-free nutritional products [4][11]. Group 3: Clinical Research and Findings - Clinical studies conducted in collaboration with reputable institutions have shown that Inne's proprietary ingredient, Kidtal, significantly promotes growth and bone health in children aged 2-12 [7][8]. - Research published in the international journal "Nutrients" has validated the effectiveness of Kidtal, enhancing its credibility in the scientific community [8][9]. Group 4: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen clinical research collaborations to provide safer, more effective nutritional solutions for children's health [15].